INDP / Indaptus Therapeutics, Inc. - Institutionelt ejerskab - Købere

Indaptus Therapeutics, Inc.

Institutionelt og fondsejerskab - Købere

Større indehavere, der har åbnet nye stillinger i Indaptus Therapeutics, Inc., omfatter VEXMX - Vanguard Extended Market Index Fund Investor Shares, SBI Securities Co., Ltd., Tower Research Capital LLC (TRC), Bank Of America Corp /de/, Fmr Llc, Wells Fargo & Company/mn, og Proequities, Inc. .

Denne side viser ændringer i ejerskabsstrukturen ved at notere institutioner, fonde og større aktionærer, der har øget deres beholdning eller åbnet nye positioner i den seneste rapporteringsperiode. Grønne rækker angiver nye positioner. Klik på linket ikon for at se den fulde transaktionshistorik.

Opgrader for at låse op for premium-data.

Fil dato Kilde Investor Type Gennemsnitlig pris
(Øst)
Aktier Δ Aktier
(%)
Rapporteret
Værdi
($1000)
Δ Værdi
(%)
Port Alloc
(%)
2025-08-14 13F Fmr Llc 10 0
2025-08-15 13F Tower Research Capital LLC (TRC) 108 1
2025-08-08 13F SBI Securities Co., Ltd. 156 2
2025-08-14 13F Bank Of America Corp /de/ 31 0
2025-08-27 NP VEXMX - Vanguard Extended Market Index Fund Investor Shares This fund is a listed as child fund of Vanguard Group Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 966 10
2025-08-14 13F Wells Fargo & Company/mn 2 0
2025-08-12 13F Proequities, Inc. 0 0
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista